Evidence-Based Medicine Working Group

Evidence-Based Medicine Working Group
Name	Evidence-Based Medicine Working Group
Formation	1990s
Headquarters	McMaster University?
Type	Working group
Field	Medicine

Evidence-Based Medicine Working Group The Evidence-Based Medicine Working Group was a coalition of clinicians and academics formed to promote systematic approaches to clinical practice and healthcare decision-making through critical appraisal of research and integration of evidence into patient care. It emerged alongside influential figures and institutions in the early 1990s and interacted with leading journals, universities, guideline bodies, and funding agencies to reshape internal medicine, general practice, and public health approaches internationally. The group’s members published in high-profile journals and collaborated with organizations that included research centers, professional societies, and governmental advisory bodies.

History

The origins trace to discussions among clinicians at McMaster University, Oxford University, and Harvard University prompted by methodological debates in randomized controlled trials and systematic review practice during the late 1980s and early 1990s. Influences included the methodological reform movements tied to figures at Guy's Hospital, Cochrane Collaboration, Royal College of Physicians, and the National Institutes of Health where concerns about bias in clinical trials, reproducibility from Johns Hopkins University, and guideline inconsistency at NHS institutions prompted coordinated responses. The group convened workshops involving editors from The BMJ, The Lancet, and JAMA and collaborated with methodologists from University of Oxford, McMaster University, University of Toronto, and Stanford University to formalize evidence appraisal standards.

Membership and Organization

Membership included physicians, epidemiologists, statisticians, and journal editors affiliated with institutions such as McMaster University, University of Oxford, Harvard Medical School, University of Toronto, Yale University, Columbia University, University College London, and Karolinska Institutet. The group liaised with editorial teams at The BMJ, JAMA, The Lancet, Annals of Internal Medicine, and professional bodies like the Royal College of Physicians, American Medical Association, American College of Physicians, and the Cochrane Collaboration. Organizational links extended to research funders such as the Wellcome Trust, National Institutes of Health, Medical Research Council (United Kingdom), and the European Commission, as well as guideline developers including National Institute for Health and Care Excellence and Agency for Healthcare Research and Quality. It also engaged with disciplinary networks at McMaster Health Forum, Oxford Centre for Evidence-Based Medicine, and Centre for Evidence-Based Medicine collaborators in Europe and North America.

Key Contributions and Publications

The group’s prominent outputs included methodological papers in The BMJ, JAMA, and Annals of Internal Medicine that defined standards for randomized controlled trial appraisal, grading of evidence, and systematic review methodology. They contributed to reporting standards that influenced CONSORT, PRISMA, and evidence synthesis approaches used by Cochrane Collaboration reviews, and provided frameworks that informed NICE guideline methods. Collaborative publications shaped how editors at The Lancet and BMJ Group judged trial reporting and how institutions such as World Health Organization and Centers for Disease Control and Prevention integrated evidence into policy advisories. Their work intersected with influential texts and authors from Guyatt, Sackett, and other methodologists affiliated with McMaster University and University of Oxford.

Influence on Clinical Practice and Policy

The group’s guidance affected clinical guideline development at National Institute for Health and Care Excellence, Scottish Intercollegiate Guidelines Network, and national health agencies including the Centers for Disease Control and Prevention and Health Canada. Hospitals and professional colleges like the American College of Physicians adopted evidence appraisal techniques in training curricula at Harvard Medical School, University of Toronto, Yale School of Medicine, and Stanford School of Medicine. Their influence extended to research funding priorities at the Wellcome Trust, National Institutes of Health, and Medical Research Council (United Kingdom), promoting randomized trials, systematic reviews, and patient-centered outcomes research championed by organizations such as the Institute of Medicine and the Patient-Centered Outcomes Research Institute.

Criticisms and Controversies

Critiques arose from clinicians and scholars at institutions including Cambridge University, Imperial College London, and various national academies who argued that strict evidence hierarchies undervalued clinical expertise and context in fields like psychiatry and palliative care. Debates involved editors from The Lancet and commentators in The BMJ about applicability of trial-derived recommendations to complex patients seen in settings such as primary care clinics affiliated with King’s College London and University College London Hospitals. Conflicts concerned guideline rigidity criticized by professional bodies like the Royal College of General Practitioners and questions about influence from funding bodies such as the Wellcome Trust and NIH.

Legacy and Successors

The Working Group’s concepts seeded successors including the development of evidence grading systems at NICE, expansion of the Cochrane Collaboration, establishment of reporting standards like PRISMA and CONSORT, and institutional programs at McMaster University and Oxford that continue methodological training. Its legacy persists through guideline bodies, training curricula at Harvard Medical School and Yale School of Medicine, and research infrastructures at Patient-Centered Outcomes Research Institute and the Agency for Healthcare Research and Quality, while ongoing debates at World Health Organization forums and academic centers ensure continued evolution of evidence-based practice.

Category:Evidence-based medicine